Loading
Huapont Life Sciences Co.,Ltd.: what insiders have been doing
Every trade that managers of Huapont Life Sciences Co.,Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Chemicals sector. Between 26 October 2025 and 26 October 2026, 1 insider published 3 filings.
The flow runs one way only: 3 sales worth €584k, from 1 insider, and no purchase. At €399k, the sale published on 18 November 2025 by 王榕 is the largest of the period.
Compared with its exchange (533 companies, median 2 filings), a count of 3 filings is above the norm. Since 2021, the database holds no purchases and 5 sales by insiders of the company.
Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
In the same sector, recent insider purchases at Culp Inc also feature in our signals. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€2M
5 ops. · all time
Who traded when
BuySale王榕3 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 5,630 of 26,320 companies
66.2
score / 100
Value84
Quality49
FCF yld17%
Earn yld8.6%
EV/EBITDA6.4x
ROE5.2%
Gross mgn37%
Net mgn6.2%
Debt/EBITDA3.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥4.48
Analyst consensus
Income statement
RevenueCN¥11.5B
Gross profitCN¥4.3B37% margin
EBITDACN¥2.4B21% margin
Net incomeCN¥713.2M5.6% margin
Valuation
PER (trailing)13.6x
P/Book0.9x
Beta0.32
Balance sheet & cash
Market capCN¥8.9B
Total debtCN¥7.3B
Free Cash FlowCN¥1.5B
Debt / Equity45%
Profitability & ownership
ROE5.2%
ROA3.0%
% insiders34.5%
% institutions4.4%
Last declaration on 9 October 2026
Declarations5 total
50,000 shares@ CN¥33.83551.6% of flowA股XSHESZSE:273000001694628030
650,000 shares21.8% of flowA股XSHESZSE:173000009801096930
250,000 shares8.5% of flowA股XSHESZSE:173000009752044700
929,100 shares37.1% of flowA股XSHESZSE:173000006080903680
600,000 shares32.6% of flowA股XSHESZSE:173000005252183800
5 of 5 declarations
About Huapont Life Sciences Co.,Ltd.
华邦健康 is a company operating in the chemical and materials sector, listed on the XSHE market. It specializes in the production of chemical products and health materials.
